Dec 9 (Reuters) - Eli Lilly said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in Huntsville, Alabama, to expand U.S. production and bolster medicine supply chains.
The site, the third new U.S. facility announced by Lilly, will make small-molecule synthetic and peptide medicines, including orforglipron, its first oral GLP-1 weight-loss drug anticipated to receive U.S. approval early next year.
Global pharmaceutical companies have been increasing U.S. investments after President Donald Trump urged the industry to make more medicines domestically rather than importing active ingredients or finished medicines.
Earlier this year, Lilly outlined plans to spend at least $27 billion on four new U.S. manufacturing sites to counter potential drug import duties. Lilly said another location will be announced in the coming weeks.
The company said the construction is slated to begin in 2026, creating about 3,000 construction jobs, with completion targeted for 2032. Lilly also plans 450 roles for engineers, scientists, operations personnel and lab technicians in the area.
CEO David Ricks said the investment advances the onshoring of active pharmaceutical ingredient production to strengthen supply resilience.
The company estimates every dollar invested could generate up to four dollars in local economic activity.
The site was chosen from more than 300 applications, aided by proximity to the HudsonAlpha Institute for Biotechnology, an established bioscience campus supporting workforce training and research, Lilly said.
Alabama Governor Kay Ivey called the project "the largest initial investment in our state's history."
Lilly said the plant will use machine learning, AI and digitally integrated monitoring systems, with automation embedded across operations.
The company also aims to work toward carbon neutrality at the site, said Edgardo Hernandez, Lilly's manufacturing operations head.
(Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
They died 'doing what they loved': The stories of workers in their 80s who died on the job - 2Iran war upends aviation strategies
- 3Opening Potential: Self-awareness and Long lasting Learning
- 45 Chiefs That Changed Our Opinion on Film
- 5Find the Wonders of the Silk Street: Following the Antiquated Shipping lanes
- More parents refusing vitamin K shots for newborns, study finds
- BioMarin to acquire Amicus Therapeutics for $4.8 billion in rare disease bet
- Pick Your Favored kind of salad
- Artemis II astronauts find hidden Easter eggs as they close in on the moon
- We analyzed Philly street scenes and identified signs of gentrification using machine learning trained on longtime residents’ observations
- 6 Solid Vehicle Fix Administrations to Keep Your Vehicle in Prime Condition
- Ergonomic Office Seats for Work spaces
- Russia earning billions from Hormuz blockade, German trade body says
- South Carolina's measles outbreak reaches 434 cases
